David J. Lockhart
2007
In 2007, David J. Lockhart earned a total compensation of $1M as Chief Scientific Officer at Amicus Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $106,848 |
|---|---|
| Option Awards | $540,051 |
| Salary | $296,154 |
| Other | $59,281 |
| Total | $1,002,334 |
Lockhart received $540.1K in option awards, accounting for 54% of the total pay in 2007.
Lockhart also received $106.8K in non-equity incentive plan, $296.2K in salary and $59.3K in other compensation.
Rankings
In 2007, David J. Lockhart's compensation ranked 4,113th out of 8,700 executives tracked by ExecPay. In other words, Lockhart earned more than 52.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,113 out of 8,700 | 53rd |
Division Manufacturing | 1,479 out of 3,314 | 55th |
Major group Chemicals And Allied Products | 281 out of 746 | 62nd |
Industry group Drugs | 162 out of 546 | 70th |
Industry Pharmaceutical Preparations | 118 out of 364 | 68th |
Source: SEC filing on April 24, 2009.
Lockhart's colleagues
We found four more compensation records of executives who worked with David J. Lockhart at Amicus Therapeutics in 2007.